Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer

Abstract

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTRecent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and CancerAndrew P. Combs†View Author Information Incyte Corporation, Experimental Station, E336/131A, Route 141 and Henry Clay Road, Wilmington, Delaware 19880†Contact information. Phone: [phone]. Fax: [phone]. E-mail: [email protected]Cite this: J. Med. Chem. 2010, 53, 6, 2333–2344Publication Date (Web):December 10, 2009Publication History Received22 July 2009Published online10 December 2009Published inissue 25 March 2010https://pubs.acs.org/doi/10.1021/jm901090bhttps://doi.org/10.1021/jm901090breview-articleACS PublicationsCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views6833Altmetric-Citations270LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Drug discovery,Inhibitors,Peptides and proteins,Permeability,Pharmaceuticals Get e-Alerts